Search Results 311-320 of 15761 for Prednisone

1. Mayo Clinic Q and A: Treating osteoarthritis with corticosteroid injections

   DEAR MAYO CLINIC: I have osteoarthritis in my knee that continues to worsen. Would a steroid injection help my knee pain? How long does the treatment last, ...

2. Clinical trials - Oncology (Medical)

   ... prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for ...

3. A Study To Compare The Effectiveness Of Three Eye Corticosteroids For Treating Uveitic Macular Edema - Mayo Clinic

   ... prednisone 10 mg per day); Oral prednisone dose ≤ 10 mg per day that has not been stable for at least 4 weeks; Systemic immunosuppressive drug therapy ...

4. Macular Edema Ranibizumab V. Intravitreal Anti-inflammatory Therapy Trial - Mayo Clinic

   Oral prednisone dose > 10 mg per day (or of an alternative corticosteroid at a dose higher than that equipotent to prednisone 10 mg per day) OR oral prednisone ...

5. Castleman disease - Diagnosis and treatment - Mayo Clinic

   Corticosteroids such as prednisone can help control inflammation. Chemotherapy can get rid of immune cells that are causing problems. When siltuximab doesn ...

6. Clinical trials - Oncology (Medical)

   ... prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for ...

7. A Study Of The Efficacy And Safety Of Upadacitinib (ABT-494) In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   ... prednisone (or equivalent) ≥ 40 mg/day orally for at least 3 weeks or intravenously for 1 week; OR; Inability to taper corticosteroids at or below a dose ...

8. Find clinical trials - Hematology

   ... prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for ...

9. Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

   ... prednisone) chemotherapy. The anti-folate pralatrexate, the first drug approved for patients with relapsed/refractory PTCL, provided a rationale to ...

10. A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) - Mayo Clinic

    The study is a Phase II randomized, open label, multicenter trial designed to identify whether sirolimus is a potential alternative to prednisone as an up ...